Literature DB >> 18256523

The common germline Arg72Pro polymorphism of p53 and increased longevity in humans.

Stig E Bojesen1, Børge G Nordestgaard.   

Abstract

More than ten million single nucleotide polymorphisms (SNPs) have been identified in humans; however, the importance of most SNPs for health and disease is not understood. Most SNPs are indeed unimportant and because of often inadequately powered studies, many observations on SNP effects can not be repeated by other researchers. SNPs are at best shown to influence protein function or level, rarely to influence risk of disease, and almost never to influence total mortality, the ultimate endpoint. A wellknown functional SNP in the tumor suppressor TP53 gene leads to increased longevity: in the Danish general population (n = 9219) homozygotes for the minor allele versus homozygotes for the major allele had an increase in median survival of 3 years. This is partly explained by increased survival after development of cancer or other diseases, in accordance with the observation that this Arg72Pro substitution in the p53 protein has important influence on cell death via increased apoptosis. Thus, the increased longevity may be due to a generally increased robustness after a diagnosis of any life-threatening disease. In contrast to widespread skepticism on the importance of SNPs in humans, this gain-of-function p53 SNP of importance for cell repair mechanisms has a profound influence on longevity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18256523     DOI: 10.4161/cc.7.2.5249

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  32 in total

1.  Polygenic effects of common single-nucleotide polymorphisms on life span: when association meets causality.

Authors:  Anatoliy I Yashin; Deqing Wu; Konstantin G Arbeev; Svetlana V Ukraintseva
Journal:  Rejuvenation Res       Date:  2012-04-25       Impact factor: 4.663

Review 2.  Genome maintenance and human longevity.

Authors:  Miook Cho; Yousin Suh
Journal:  Curr Opin Genet Dev       Date:  2014-08-28       Impact factor: 5.578

Review 3.  Genetic epidemiology in aging research.

Authors:  M Daniele Fallin; Amy Matteini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-23       Impact factor: 6.053

4.  Rapamycin induces pluripotent genes associated with avoidance of replicative senescence.

Authors:  Tatiana V Pospelova; Tatiana V Bykova; Svetlana G Zubova; Natalia V Katolikova; Natalia M Yartzeva; Valery A Pospelov
Journal:  Cell Cycle       Date:  2013-12-02       Impact factor: 4.534

Review 5.  Mitochondrial maintenance failure in aging and role of sexual dimorphism.

Authors:  John Tower
Journal:  Arch Biochem Biophys       Date:  2014-10-25       Impact factor: 4.013

6.  Respected Sir(2): magic target for diabetes.

Authors:  Pratibha V Nerurkar; Vivek R Nerurkar
Journal:  Cellscience       Date:  2008-04-27

7.  TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer.

Authors:  Ana Coelho; Augusto Nogueira; Sílvia Soares; Joana Assis; Deolinda Pereira; Isabel Bravo; Raquel Catarino; Rui Medeiros
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

8.  Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time.

Authors:  Erwin Reiling; Valeriya Lyssenko; Jolanda M A Boer; Sandra Imholz; W Monique M Verschuren; Bo Isomaa; Tiinamaija Tuomi; Leif Groop; Martijn E T Dollé
Journal:  Eur J Hum Genet       Date:  2011-12-21       Impact factor: 4.246

9.  Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.

Authors:  Md Shaki Mostaid; Maizbha Uddin Ahmed; Mohammad Safiqul Islam; Muhammad Shahdaat Bin Sayeed; Abul Hasnat
Journal:  Tumour Biol       Date:  2014-07-18

10.  Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.

Authors:  Charles C Weige; Marc R Birtwistle; Himel Mallick; Nengjun Yi; Zuzana Berrong; Emily Cloessner; Keely Duff; Josephine Tidwell; Megan Clendenning; Brent Wilkerson; Christopher Farrell; Fred Bunz; Hao Ji; Michael Shtutman; Kim E Creek; Carolyn E Banister; Phillip J Buckhaults
Journal:  Mol Cancer Res       Date:  2014-04-17       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.